ENFN logo

Enfusion (ENFN) Gross Profit

Annual Gross Profit

$136.74 M
+$19.84 M+16.98%

December 31, 2024


Summary


Performance

ENFN Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENFNprofitabilitymetrics:

Quarterly Gross Profit

$36.54 M
+$1.71 M+4.92%

December 31, 2024


Summary


Performance

ENFN Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENFNprofitabilitymetrics:

TTM Gross Profit

$136.74 M
+$5.68 M+4.33%

December 31, 2024


Summary


Performance

ENFN TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENFNprofitabilitymetrics:

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

ENFN Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.0%+18.4%+17.0%
3 y3 years+71.2%+22.4%+20.7%
5 y5 years+225.1%+22.4%+20.7%

ENFN Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+71.2%at high+68.5%at high+71.2%
5 y5-yearat high+225.1%at high+153.9%at high+850.1%
alltimeall timeat high+225.1%at high+153.9%at high+850.1%

Enfusion Gross Profit History

DateAnnualQuarterlyTTM
Dec 2024
$136.74 M(+17.0%)
$36.54 M(+4.9%)
$136.74 M(+4.3%)
Sep 2024
-
$34.83 M(+4.0%)
$131.06 M(+3.9%)
Jun 2024
-
$33.49 M(+5.1%)
$126.08 M(+4.1%)
Mar 2024
-
$31.88 M(+3.3%)
$121.10 M(+3.6%)
Dec 2023
$116.89 M(+13.2%)
$30.86 M(+3.4%)
$116.89 M(+3.2%)
Sep 2023
-
$29.85 M(+4.7%)
$113.25 M(+2.4%)
Jun 2023
-
$28.51 M(+3.1%)
$110.58 M(+2.6%)
Mar 2023
-
$27.67 M(+1.6%)
$107.76 M(+4.4%)
Dec 2022
$103.25 M
$27.22 M(+0.2%)
$103.25 M(+5.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
$27.18 M(+5.8%)
$97.72 M(+6.8%)
Jun 2022
-
$25.69 M(+10.9%)
$91.49 M(+7.0%)
Mar 2022
-
$23.16 M(+6.8%)
$85.47 M(+7.0%)
Dec 2021
$79.86 M(+37.2%)
$21.69 M(+3.5%)
$79.86 M(+6.9%)
Sep 2021
-
$20.95 M(+6.5%)
$74.67 M(+9.6%)
Jun 2021
-
$19.67 M(+12.1%)
$68.11 M(+40.6%)
Mar 2021
-
$17.54 M(+6.3%)
$48.44 M(+56.8%)
Dec 2020
$58.21 M(+38.4%)
$16.50 M(+14.7%)
$30.89 M(+114.7%)
Sep 2020
-
$14.39 M
$14.39 M
Dec 2019
$42.07 M
-
-

FAQ

  • What is Enfusion annual gross profit?
  • What is the all time high annual gross profit for Enfusion?
  • What is Enfusion annual gross profit year-on-year change?
  • What is Enfusion quarterly gross profit?
  • What is the all time high quarterly gross profit for Enfusion?
  • What is Enfusion quarterly gross profit year-on-year change?
  • What is Enfusion TTM gross profit?
  • What is the all time high TTM gross profit for Enfusion?
  • What is Enfusion TTM gross profit year-on-year change?

What is Enfusion annual gross profit?

The current annual gross profit of ENFN is $136.74 M

What is the all time high annual gross profit for Enfusion?

Enfusion all-time high annual gross profit is $136.74 M

What is Enfusion annual gross profit year-on-year change?

Over the past year, ENFN annual gross profit has changed by +$19.84 M (+16.98%)

What is Enfusion quarterly gross profit?

The current quarterly gross profit of ENFN is $36.54 M

What is the all time high quarterly gross profit for Enfusion?

Enfusion all-time high quarterly gross profit is $36.54 M

What is Enfusion quarterly gross profit year-on-year change?

Over the past year, ENFN quarterly gross profit has changed by +$5.68 M (+18.40%)

What is Enfusion TTM gross profit?

The current TTM gross profit of ENFN is $136.74 M

What is the all time high TTM gross profit for Enfusion?

Enfusion all-time high TTM gross profit is $136.74 M

What is Enfusion TTM gross profit year-on-year change?

Over the past year, ENFN TTM gross profit has changed by +$19.84 M (+16.98%)